ACIU · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.3B · 122 employees
147
SEC Filings
$2.28
Close 2026-08-10
122
Employees
Business Summary
AC Immune SA is a clinical-stage biopharmaceutical company focused on neurodegenerative diseases. It develops active immunotherapies (ACI-35.030, ACI-24.060, ACI-7104.056), small molecule drug programs (ACI-19764, an NLRP3 inhibitor; Morphomer Tau; Morphomer-a-syn), and diagnostics including PET tracers (PI-2620 Tau-PET, ACI-12589 and ACI-15916 alpha-synuclein PET, ACI-19626 TDP-43-PET). The company uses proprietary Morphomer and SupraAntigen technology platforms and relies on collaboration partners for clinical development.
Latest Stock Quote
ACIU 2026-08-10 $2.28
O:$2.36 H:$2.37 L:$2.28 Vol:0.1M VWAP:$2.3102
origin leaf: null
147 total filings indexed. 147 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Look up ACIU using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on ACIU, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/ACIU (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.